First Patient Enrolled in Abiomed's RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock
First trial in AMI cardiogenic shock to use the FDA’s EFIC protocol
Source: dicardiology.com
📰 Mark Bieniarz News
Mark Bieniarz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Bieniarz. Real-time updates on events, politics, business and more.
Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock
Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).
United States Johnson Medtech Chuck Simonton Mark Bieniarz Drug Administration Mexico Heart Institute
Source: news-medical.net
FDA approves heart pump study in New Mexico
An FDA-approved heart pump study is being conducted here in New Mexico with the goal of improving recovery for heart attack patients.
New Mexico United States Mark Bieniarz Mexico Heart Institute At Lovelace Medical Center New Mexico Heart Institute Lovelace Medical Center
Source: kob.com